|  | Conditions & Treatments | Diseases

Pethidine (Meperidine) Nursing Implications: Monitoring, Risks & Patient Education

Nursing Care Guide for Pethidine (Meperidine) Administration

Pethidine (meperidine) is a phenylpiperidine opioid agonist with atypical properties: local anesthetic effect, anticholinergic activity, and a neurotoxic metabolite (normeperidine). Not first-line for chronic pain.

Key Nursing Implications

1. Respiratory Depression — High Risk

  • More pronounced in elderly, renal/hepatic impairment, opioid-naïve, concurrent CNS depressants (benzos, alcohol, gabapentinoids).
  • Monitor: RR, depth, SpO₂, EtCO₂ q15–30 min × 1h, then q1–2h.
  • Position: Semi-Fowler’s; supplemental O₂ if SpO₂ <94%.
  • Naloxone at bedside; dilute for titration (0.4 mg in 10 mL NS → 0.04 mg/mL).

2. CNS Effects: Sedation, Confusion, Seizures

  • Normeperidine accumulates in renal failure → CNS excitation: myoclonus, seizures (not reversed by naloxone).
  • Monitor LOC (RASS/SBS), pupil size, orientation.
  • Avoid in seizure disorders; use alternative opioids (morphine, hydromorphone, fentanyl).

3. Cardiovascular: Hypotension

  • Venous dilation + histamine release → orthostatic hypotension.
  • Monitor BP q15–30 min initially; avoid rapid position changes.
  • Caution in hypovolemia, cardiac tamponade, severe CAD.

4. Anticholinergic Effects

  • Dry mouth, blurred vision, urinary retention, constipation, tachycardia.
  • Encourage fluids, fiber, mobility; monitor I&O; stool softeners PRN.

5. Gastrointestinal: Nausea/Vomiting

  • CTZ stimulation + vestibular effect.
  • Prophylactic antiemetic (ondansetron 4 mg IV) if high risk.

6. Drug Interactions — Critical

  • MAOIs: Serotonin syndrome, hypertensive crisis — contraindicated within 14 days.
  • SSRIs/SNRIs/TCAs: Serotonin syndrome risk.
  • CYP3A4/2D6 inhibitors/inducers alter metabolism.
  • Other opioids, benzos, sedatives, alcohol: Additive CNS depression.

7. Dependence & Withdrawal

  • Short half-life (3–4h) → rapid onset withdrawal if stopped abruptly after chronic use.
  • Taper gradually; use COWS scale.

8. Monitoring & Documentation

  • Pain scores (0–10) pre/post 30–60 min.
  • Vitals, respiratory assessment, sedation level, bowel/bladder function.
  • Document indication, dose, route, response, adverse effects.

9. Patient Education

  • Do not drive/operate machinery.
  • Report excessive drowsiness, difficulty breathing, muscle twitching.
  • Avoid alcohol/CNS depressants.
  • Constipation prevention (fluids, fiber, laxatives).
  • Do not share medication; secure storage.

Special Populations

  • Renal Failure: Avoid (normeperidine accumulation); use fentanyl/methadone.
  • Pediatrics: Not recommended <12y (seizure risk); weight-based dosing if used.
  • Obstetrics: Crosses placenta; neonatal respiratory depression. Use morphine/fentanyl preferred.

Bottom line: Pethidine has a narrow therapeutic window and unique toxicities. Most guidelines recommend avoiding it in favor of safer opioids.

Diseases - Related Articles